Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases

被引:116
作者
Candore, Gianmario [1 ]
Juhlin, Kristina [2 ]
Manlik, Katrin [3 ]
Thakrar, Bharat [4 ]
Quarcoo, Naashika [5 ]
Seabroke, Suzie [6 ]
Wisniewski, Antoni [7 ]
Slattery, Jim [1 ]
机构
[1] European Medicines Agcy, London E14 4HB, England
[2] Uppsala Monitoring Ctr, Uppsala, Sweden
[3] Bayer Pharma AG, Berlin, Germany
[4] Roche, Basel, Switzerland
[5] GlaxoSmithKline, London, England
[6] UK Med & Healthcare Prod Regulatory Agcy, London, England
[7] AstraZeneca, Alderley Pk, Cheshire, England
关键词
ADVERSE DRUG-REACTIONS; RETROSPECTIVE EVALUATION; DETECTION ALGORITHMS; PHARMACOVIGILANCE; GENERATION; SAFETY; DISPROPORTIONALITY; PERFORMANCE; RATIOS; SYSTEM;
D O I
10.1007/s40264-015-0289-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Most pharmacovigilance departments maintain a system to identify adverse drug reactions (ADRs) through analysis of spontaneous reports. The signal detection algorithms (SDAs) and the nature of the reporting databases vary between operators and it is unclear whether any algorithm can be expected to provide good performance in a wide range of environments. The objective of this study was to compare the performance of commonly used algorithms across spontaneous reporting databases operated by pharmaceutical companies and national and international pharmacovigilance organisations. 220 products were chosen and a reference set of ADRs was compiled. Within four company, one national and two international databases, 15 SDAs based on five disproportionality methods were tested. Signals of disproportionate reporting (SDRs) were calculated at monthly intervals and classified by comparison with the reference set. These results were summarised as sensitivity and precision for each algorithm in each database. Different algorithms performed differently between databases but no method dominated all others. Performance was strongly dependent on the thresholds used to define a statistical signal. However, the different disproportionality statistics did not influence the achievable performance. The relative performance of two algorithms was similar in different databases. Over the lifetime of a product there is a reduction in precision for any method. In designing signal detection systems, careful consideration should be given to the criteria that are used to define an SDR. The choice of disproportionality statistic does not appreciably affect the achievable range of signal detection performance and so this can primarily be based on ease of implementation, interpretation and minimisation of computing resources. The changes in sensitivity and precision obtainable by replacing one algorithm with another are predictable. However, the absolute performance of a method is specific to the database and is best assessed directly on that database. New methods may be required to gain appreciable improvements.
引用
收藏
页码:577 / 587
页数:11
相关论文
共 34 条
[1]   Perspectives on the use of data mining in pharmacovigilance [J].
Almenoff, J ;
Tonning, JM ;
Gould, AL ;
Szarfman, A ;
Hauben, M ;
Ouellet-Hellstrom, R ;
Ball, R ;
Hornbuckle, K ;
Walsh, L ;
Yee, C ;
Sacks, ST ;
Yuen, N ;
Patadia, V ;
Blum, M ;
Johnston, M ;
Gerrits, C ;
Seifert, H ;
LaCroix, K .
DRUG SAFETY, 2005, 28 (11) :981-1007
[2]   Comparative performance of two quantitative safety signalling methods - Implications for use in a pharmacovigilance department [J].
Almenoff, June S. ;
LaCroix, Karol K. ;
Yuen, Nancy A. ;
Fram, David ;
DuMouchel, William .
DRUG SAFETY, 2006, 29 (10) :875-887
[3]   Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data A Retrospective Evaluation of the Potential for Earlier Signalling [J].
Alvarez, Yolanda ;
Hidalgo, Ana ;
Maignen, Francois ;
Slattery, Jim .
DRUG SAFETY, 2010, 33 (06) :475-487
[4]   Comparing data mining methods on the VAERS database [J].
Banks, D ;
Woo, EJ ;
Burwen, DR ;
Perucci, P ;
Braun, MM ;
Ball, R .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (09) :601-609
[5]   The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database [J].
Bate, A. ;
Lindquist, M. ;
Edwards, I. R. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (02) :127-140
[6]   A Bayesian neural network method for adverse drug reaction signal generation [J].
Bate, A ;
Lindquist, M ;
Edwards, IR ;
Olsson, S ;
Orre, R ;
Lansner, A ;
De Freitas, RM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) :315-321
[7]  
Brown JS, 2011, PHARMACOEPIDEM DR S, V20, pS144
[8]   A COMPARISON OF SIGNAL DETECTION PERFORMANCE BETWEEN REPORTING ODDS RATIO AND BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK METHODS ON ADVERSE DRUG REACTION SPONTANEOUS REPORTING DATABASE OF THE THAI FDA [J].
Bunchuailua, W. ;
Zuckerman, I ;
Kulsomboon, V ;
Suwankesawong, W. ;
Singhasivanon, P. ;
Kaewkungwal, J. .
VALUE IN HEALTH, 2010, 13 (07) :A508-A508
[9]   Large-scale regression-based pattern discovery: The example of screening the WHO global drug safety database [J].
Caster O. ;
Norén G.N. ;
Madigan D. ;
Bate A. .
Statistical Analysis and Data Mining, 2010, 3 (04) :197-208
[10]   Comparison of Sensitivity and Timing of Early Signal Detection of Four Frequently Used Signal Detection MethodsAn Empirical Study Based on the US FDA Adverse Event Reporting System Database [J].
Yan Chen ;
Jeff J. Guo ;
Michael Steinbuch ;
Xiaodong Lin ;
Charles R. Buncher ;
Nick C. Patel .
Pharmaceutical Medicine, 2008, 22 (6) :359-365